94.72
전일 마감가:
$93.74
열려 있는:
$93.53
하루 거래량:
7,043
Relative Volume:
0.33
시가총액:
$281.93M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.93%
1개월 성능:
+4.05%
6개월 성능:
+15.20%
1년 성능:
+39.69%
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Compare PBE vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PBE
Invesco Biotechnology Genome Etf
|
94.72 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
382.13 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
772.67 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
776.29 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
307.97 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
729.87 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf 주식(PBE)의 최신 뉴스
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - NewsBreak: Local News & Alerts
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? - The Motley Fool
XLV vs PBE: Healthcare Sector Stability vs Biotech Growth - sekbernews.id
XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? - The Globe and Mail
PBE Dividend: 1.49% Yield, $1.55/Share — History & Dates - GuruFocus
Bio-Techne Corp (TECH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Madrigal Pharmaceuticals Inc (MDGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Gilead Sciences Inc (GILD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vertex Pharmaceuticals Inc (VRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Invesco Biotechnology & Genome ETF : PBE - 24/7 Wall St.
Biotech ETFs XBI and PBE diverge sharply in str... - Pluang
ETF Showdown: XBI vs PBE, Which Biotech Fund Wins? - Yahoo Finance
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Full Year Ended April 30, 2026 - marketscreener.com
PBEInvesco Biotechnology & Genome ETF Earnings - Finviz
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.8106 - MSN
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
United Therapeutics Corp (UTHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Regeneron Pharmaceuticals Inc (REGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Exelixis Inc (EXEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Should you invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
(PBE) Risk Channels and Responsive Allocation - Stock Traders Daily
3 ETFs For the Coming Genomics Revolution - Yahoo Finance
(PBE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
BIOY Stock Fund Price and Chart — NASDAQ:BIOY - TradingView
Is Invesco Global Clean Energy ETF (PBD) a Strong ETF Right Now? - Yahoo Finance
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.0824 - MSN
Understanding Momentum Shifts in (PBE) - Stock Traders Daily
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Is Invesco Biotechnology & Genome ETF (PBE) a strong ETF right now? - MSN
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
Invesco Dynamic Biotechnology & Genome ETF (PBE) - Minichart
Invesco Biotechnology Genome Etf (PBE) 재무 분석
Invesco Biotechnology Genome Etf (PBE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):